{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:06:35Z","timestamp":1788588395002,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jaad.2013.09.010","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T01:16:17Z","timestamp":1392254177000},"page":"401.e1-401.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Safety of dermatologic medications in pregnancy and lactation"],"prefix":"10.1016","volume":"70","author":[{"given":"Jenny E.","family":"Murase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha M.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.09.010_bib1","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.jaad.2013.09.010_bib3","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/jid.2010.392","article-title":"Safety of topical corticosteroids in pregnancy: a population-based cohort study","volume":"131","author":"Chi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib4","first-page":"CD007346","article-title":"Safety of topical corticosteroids in pregnancy","author":"Chi","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2013.09.010_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","article-title":"Population-based case-control study of teratogenic potential of corticosteroids","volume":"56","author":"Czeizel","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2013.09.010_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bdra.10134","article-title":"First trimester exposure to corticosteroids and oral clefts","volume":"67","author":"Pradat","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jaad.2013.09.010_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-0412.2002.810308.x","article-title":"Risk of intrauterine growth retardation, malformations and other birth outcomes in children after topical use of corticosteroid in pregnancy","volume":"81","author":"Mygind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaad.2013.09.010_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.trstmh.2006.06.007","article-title":"The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice","volume":"101","author":"Mahe","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2013.09.010_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2133.2011.10513.x","article-title":"Evidence-based (S3) guideline on topical corticosteroids in pregnancy","volume":"165","author":"Chi","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib10","series-title":"Drugs during pregnancy and lactation: treatment options and risk assessment","author":"Schaefer","year":"2007"},{"key":"10.1016\/j.jaad.2013.09.010_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0272-0590(89)90324-2","article-title":"Comparison of fetotoxic effects of a dermally applied complex organic mixture in rats and mice","volume":"13","author":"Zangar","year":"1989","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/000155599750010373","article-title":"A retrospective study of the teratogenicity of dermatological coal tar products","volume":"79","author":"Franssen","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.09.010_bib13","series-title":"Dovonex [product insert]","year":"2011"},{"key":"10.1016\/j.jaad.2013.09.010_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0002-9343(90)90522-F","article-title":"Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease","volume":"88","author":"Kozlowski","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2013.09.010_bib15","first-page":"599","article-title":"Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester","volume":"99","author":"Nguyen","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007890-199402270-00004","article-title":"National transplantation Pregnancy Registry\u2013outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients","volume":"57","author":"Armenti","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.09.010_bib17","first-page":"69","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation","author":"Armenti","year":"2005","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2013.09.010_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.09.010_bib19","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/S0041-1345(97)00458-2","article-title":"Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun","volume":"29","author":"Lamarque","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.09.010_bib20","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0041-1345(98)00408-4","article-title":"Pregnancy outcomes in female renal transplant recipients","volume":"30","author":"Armenti","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.09.010_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11316280-000000000-00000","article-title":"Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant","volume":"12","author":"Nulman","year":"2010","journal-title":"Paediatr Drugs"},{"issue":"2 Suppl","key":"10.1016\/j.jaad.2013.09.010_bib22","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1016\/j.transproceed.2004.01.012","article-title":"Renal outcome of children exposed to cyclosporine in utero","volume":"36","author":"Cochat","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2013.09.010_bib23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199307000-00044","article-title":"Long-term nephrotoxicity after exposure to cyclosporine in utero","volume":"56","author":"Shaheen","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2013.09.010_bib24","first-page":"1014","article-title":"Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship","volume":"33","author":"Carter","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3899\/jrheum.080545","article-title":"A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database","volume":"36","author":"Carter","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib26","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.3899\/jrheum.090141","article-title":"Was risk properly assessed in Carter, et\u00a0al's safety assessment of tumor necrosis factor antagonists during pregnancy?","volume":"36","author":"Winger","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2010.140822","article-title":"Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register","volume":"70","author":"Verstappen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.09.010_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cgh.2006.07.018","article-title":"Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn","volume":"4","author":"Vasiliauskas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.jaad.2013.09.010_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdrb.20250","article-title":"Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12\/23p40 monoclonal antibody, during pregnancy and lactation","volume":"89","author":"Martin","year":"2010","journal-title":"Birth\u00a0Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib31","first-page":"409","article-title":"Are\u00a0new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study","volume":"53","author":"Chambers","year":"2007","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jaad.2013.09.010_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3315\/jdcr.2012.1116","article-title":"Spontaneous abortion during ustekinumab therapy","volume":"6","author":"Fotiadou","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.jaad.2013.09.010_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2011.07.039","article-title":"Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation","volume":"67","author":"Bae","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10103-011-0895-0","article-title":"Effect of narrowband ultraviolet B phototherapy on serum folic acid levels in patients with psoriasis","volume":"26","author":"EI-Saie","year":"2011","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.jaad.2013.09.010_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jphotobiol.2010.01.013","article-title":"Pilot study of folate status in healthy volunteers and in patients with psoriasis before and after UV exposure","volume":"101","author":"Juzeniene","year":"2010","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.jaad.2013.09.010_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-8628(19960216)67:1<106::AID-AJMG19>3.0.CO;2-S","article-title":"Ultraviolet light-related neural tube defects?","volume":"67","author":"Lapunzina","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jaad.2013.09.010_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archdermatol.2011.1614","article-title":"Narrowband UV-B phototherapy during pregnancy and folic acid depletion","volume":"148","author":"Park","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archderm.1991.01680030067008","article-title":"Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis","volume":"127","author":"Stern","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.1993.01680240060006","article-title":"Psoralen photochemotherapy (PUVA) and pregnancy","volume":"129","author":"Gunnarskog","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib40","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11596240-000000000-00000","article-title":"Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management","volume":"71","author":"Makol","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2013.09.010_bib41","series-title":"Drugs in pregnancy and lactation","author":"Briggs RF","year":"2008"},{"key":"10.1016\/j.jaad.2013.09.010_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2013.09.010_bib43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/14740338.2011.566555","article-title":"Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy","volume":"10","author":"Abarientos","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2013.09.010_bib44","first-page":"CD000169","article-title":"Drugs for preventing malaria in pregnant women","author":"Garner","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2013.09.010_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2013.09.010_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2013.09.010_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1546-0096-7-9","article-title":"Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases","volume":"7","author":"Sperber","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaad.2013.09.010_bib48","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.3899\/jrheum.110686","article-title":"Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature","volume":"38","author":"Osadchy","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib49","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib50","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.09.010_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.089268","article-title":"Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA\/Ro-antibody-associated cardiac manifestations of neonatal lupus","volume":"126","author":"Izmirly","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2013.09.010_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488606775252584","article-title":"Antimalarial drugs in pregnancy: a review","volume":"1","author":"Nosten","year":"2006","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jaad.2013.09.010_bib53","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00002018-200427090-00002","article-title":"Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes","volume":"27","author":"Brabin","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2013.09.010_bib54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00007611-198905000-00037","article-title":"Neonatal hyperbilirubinemia after treatment of maternal leprosy","volume":"82","author":"Thornton","year":"1989","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2013.09.010_bib55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.5694\/j.1326-5377.1968.tb29209.x","article-title":"Neonatal haemolytic disease due to dapsone","volume":"1","author":"Hocking","year":"1968","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2013.09.010_bib56","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ajt.12238","article-title":"Mycophenolate fetal toxicity and risk evaluation and mitigation strategies","volume":"13","author":"Kim","year":"2013","journal-title":"Am J Transplant"},{"issue":"2 Pt 2","key":"10.1016\/j.jaad.2013.09.010_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.AOG.0000298347.18812.a4","article-title":"Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil?","volume":"111","author":"Schoner","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.32117","article-title":"In utero exposure to mycophenolate mofetil: a\u00a0characteristic phenotype?","volume":"146A","author":"Perez-Aytes","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2013.09.010_bib59","unstructured":"Cellcept: medication guide. Washington, DC: US Food and\u00a0Drug Administration. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM170919.pdf. Accessed May 2013."},{"key":"10.1016\/j.jaad.2013.09.010_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ibd.21154","article-title":"Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding","volume":"16","author":"Gisbert","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaad.2013.09.010_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-0528.1985.tb01088.x","article-title":"Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients","volume":"92","author":"Davison","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib62","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaad.2013.09.010_bib63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1468-3083.2010.03925.x","article-title":"Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris","volume":"25","author":"Ahmed","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.09.010_bib64","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-0960.2011.00854.x","article-title":"Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine","volume":"53","author":"Gan","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib65","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0140-6736(92)91310-5","article-title":"Is immunotherapy justified for recurrent spontaneous abortion?","volume":"339","author":"Marzusch","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib66","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1002\/art.30464","article-title":"Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block","volume":"63","author":"Routsias","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2013.09.010_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(86)80132-9","article-title":"Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy","volume":"109","author":"Sidiropoulos","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.09.010_bib68","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2013.09.010_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(74)93172-9","article-title":"Letter: cleft palate and maternal diphenhydramine intake","volume":"1","author":"Saxen","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib70","first-page":"106","article-title":"No increased risk of infant hypospadias after maternal use of loratadine in early pregnancy","volume":"3","author":"Kallen","year":"2006","journal-title":"Int\u00a0J\u00a0Med Sci"},{"key":"10.1016\/j.jaad.2013.09.010_bib71","first-page":"105","article-title":"A review of antihistamines used during pregnancy","volume":"3","author":"Kar","year":"2012","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.jaad.2013.09.010_bib72","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/oxfordjournals.aje.a114214","article-title":"Prenatal antihistamine exposure and retrolental fibroplasia","volume":"123","author":"Zierler","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaad.2013.09.010_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0889-8553(05)70350-2","article-title":"Nausea and vomiting of pregnancy","volume":"27","author":"Broussard","year":"1998","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jaad.2013.09.010_bib74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0890-6238(96)00053-6","article-title":"The developmental toxicity of the H1 histamine antagonists","volume":"10","author":"Lione","year":"1996","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib75","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.reprotox.2005.03.005","article-title":"Neonatal seizures associated with maternal hydroxyzine hydrochloride in late pregnancy","volume":"20","author":"Serreau","year":"2005","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib76","first-page":"61","article-title":"Behavioral effects of mid-pregnancy administration of lidocaine and mepivacaine in the rat","volume":"8","author":"Smith","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"key":"10.1016\/j.jaad.2013.09.010_bib77","series-title":"Birth defects and drugs in\u00a0pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.jaad.2013.09.010_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000457034","article-title":"Clinical pharmacokinetics in pregnancy and perinatology. I. Placental transfer and fetal side effects of local anaesthetic agents","volume":"8","author":"Nau","year":"1985","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.jaad.2013.09.010_bib79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1213\/00000539-198411000-00002","article-title":"Maternal, fetal, and neonatal effects of lidocaine with and without epinephrine for epidural anesthesia in obstetrics","volume":"63","author":"Abboud","year":"1984","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaad.2013.09.010_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.det.2006.01.011","article-title":"Pregnancy and dermatologic surgery","volume":"24","author":"Sweeney","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2013.09.010_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10227-002-0121-6","article-title":"Safety of topical minoxidil solution: a one-year, prospective, observational study","volume":"7","author":"Shapiro","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2013.09.010_bib82","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/bdra.10095","article-title":"Topically applied minoxidil may cause fetal malformation: a case report","volume":"67","author":"Smorlesi","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.jaad.2013.09.010_bib83","first-page":"241","article-title":"Extreme caudal agenesis. Possible drug-related etiology?","volume":"47","author":"Rojansky","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jaad.2013.09.010_bib84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09273971003793930","article-title":"Botulinum toxin and pregnancy-a cautionary tale","volume":"18","author":"Li Yim","year":"2010","journal-title":"Strabismus"},{"key":"10.1016\/j.jaad.2013.09.010_bib85","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/j.1468-1331.2012.03775.x","article-title":"Botulinum toxin A during pregnancy, still a debate","volume":"19","author":"Aranda","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaad.2013.09.010_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(05)66139-9","article-title":"Botulism and pregnancy","volume":"348","author":"Polo","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM199609123351117","article-title":"Botulism in a pregnant women","volume":"335","author":"Robin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.09.010_bib88","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-3476(75)80871-7","article-title":"Letter: observations of an infant born to a mother with botulism","volume":"87","author":"St Clair","year":"1975","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.09.010_bib89","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2044.2005.04434.x","article-title":"Botulism in a pregnant intravenous drug abuser","volume":"61","author":"Morrison","year":"2006","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaad.2013.09.010_bib90","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0368-2315(06)76453-5","article-title":"Botulism and pregnancy [in\u00a0French]","volume":"35","author":"Magri","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jaad.2013.09.010_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/009841098158863","article-title":"Human in\u00a0vivo and in\u00a0vitro hydroquinone topical bioavailability, metabolism, and disposition","volume":"54","author":"Wester","year":"1998","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.jaad.2013.09.010_bib92","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0272-0590(92)90135-5","article-title":"Hydroquinone: a developmental toxicity study in rats","volume":"18","author":"Krasavage","year":"1992","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib93","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0140-6736(92)90854-V","article-title":"Ear malformation in baby born to mother using tretinoin cream","volume":"339","author":"Camera","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib94","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/0140-6736(93)90868-H","article-title":"Multiple congenital defects associated with maternal use of topical tretinoin","volume":"341","author":"Lipson","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib95","doi-asserted-by":"crossref","first-page":"467","DOI":"10.5694\/j.1326-5377.1998.tb139031.x","article-title":"Topical tretinoin and fetal malformations","volume":"168","author":"Colley","year":"1998","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2013.09.010_bib96","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1345\/aph.17138","article-title":"Multiple congenital malformations associated with topical tretinoin","volume":"32","author":"Navarre-Belhassen","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2013.09.010_bib97","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0140-6736(93)91004-6","article-title":"First trimester topical tretinoin and congenital disorders","volume":"341","author":"Jick","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib98","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(05)63790-7","article-title":"Safety of first-trimester exposure to topical tretinoin: prospective cohort study","volume":"350","author":"Shapiro","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib99","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1177\/0091270011429566","article-title":"Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study","volume":"52","author":"Panchaud","year":"2012","journal-title":"J Clin Pharmacol"},{"issue":"2 Pt 3","key":"10.1016\/j.jaad.2013.09.010_bib100","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1067\/mjd.2000.108321","article-title":"Pharmacokinetics and safety of tazarotene","volume":"43","author":"Menter","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0190-9622(81)70004-5","article-title":"Benzoyl peroxide: percutaneous penetration and metabolic disposition","volume":"4","author":"Nacht","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib102","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2125.2006.02837.x","article-title":"Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective","volume":"63","author":"Berard","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2013.09.010_bib103","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2011.04.006","article-title":"Isotretinoin and iPledge: a view of results","volume":"65","author":"Maloney","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib104","series-title":"Information Systems Micromedex, volume 157","article-title":"POISINDEX","author":"Hall","year":"2013"},{"key":"10.1016\/j.jaad.2013.09.010_bib105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-199427010-00005","article-title":"Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules","volume":"27","author":"Heikkila","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaad.2013.09.010_bib106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","article-title":"Is erythromycin therapy teratogenic in humans?","volume":"20","author":"Kallen","year":"2005","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib107","first-page":"883","article-title":"Drug hepatotoxicity in pregnancy","volume":"3","author":"Lewis","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib108","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/AAC.12.5.630","article-title":"Hepatotoxicity of erythromycin estolate during pregnancy","volume":"12","author":"McCormack","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2013.09.010_bib109","first-page":"2112","article-title":"Fulminant pseudomembranous colitis caused by clindamycin phosphate vaginal cream","volume":"92","author":"Trexler","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2013.09.010_bib110","first-page":"87","article-title":"Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers","volume":"29","author":"Eggermont","year":"1976","journal-title":"Acta Paediatr Belg"},{"key":"10.1016\/j.jaad.2013.09.010_bib111","first-page":"23","article-title":"Failure of oral contraceptive with rifampicin","volume":"15","author":"Gupta","year":"1980","journal-title":"Med J Zambia"},{"key":"10.1016\/j.jaad.2013.09.010_bib112","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1016\/j.ijid.2011.01.007","article-title":"Exposure to trimethoprim\/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight","volume":"15","author":"Yang","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jaad.2013.09.010_bib113","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1017\/S0950268812002178","article-title":"Trimethoprim use in early pregnancy and the risk of miscarriage: a register-based nationwide cohort study","volume":"141","author":"Andersen","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jaad.2013.09.010_bib114","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7326\/0003-4819-101-4-565_1","article-title":"Trimethoprim and folinic acid","volume":"101","author":"Kinzie","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2013.09.010_bib115","first-page":"535","article-title":"Safety of the new quinolones in pregnancy","volume":"84","author":"Berkovitch","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib116","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jama.1981.03320040015021","article-title":"First-trimester drug use and congenital disorders","volume":"246","author":"Jick","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2013.09.010_bib117","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/514977","article-title":"Antifungal therapy during pregnancy","volume":"27","author":"King","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2013.09.010_bib118","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(87)92015-0","article-title":"Griseofulvin teratology, including two thoracopagus conjoined twins","volume":"1","author":"Rosa","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.09.010_bib119","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0002-9378(96)70119-9","article-title":"Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole","volume":"175","author":"Mastroiacovo","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1592\/phco.19.3.221.30919","article-title":"Pregnancy outcomes after maternal exposure to fluconazole","volume":"19","author":"Jick","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2013.09.010_bib121","first-page":"115","article-title":"Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy","volume":"46","author":"Inman","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2013.09.010_bib122","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2125.1999.00989.x","article-title":"Risk of malformations and other\u00a0outcomes in children exposed to fluconazole in utero","volume":"48","author":"Sorensen","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2013.09.010_bib123","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0006-2952(85)90613-6","article-title":"Imidazole antimycotics: inhibitors of steroid aromatase","volume":"34","author":"Mason","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaad.2013.09.010_bib124","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ERC-120015045","article-title":"Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay","volume":"28","author":"Kragie","year":"2002","journal-title":"Endocr Res"},{"key":"10.1016\/j.jaad.2013.09.010_bib125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.AOG.0000180779.35572.3a","article-title":"Genital herpes complicating pregnancy","volume":"106","author":"Brown","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2013.09.010_bib126","first-page":"1","article-title":"1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2013.09.010_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2005.06.001","article-title":"The use of topical 5% imiquimod during pregnancy: a case series","volume":"21","author":"Einarson","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00293811","article-title":"Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE)","volume":"45","author":"Strobel","year":"1980","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jaad.2013.09.010_bib129","series-title":"Non-mutagenic carcinogens: mechanisms and test\u00a0methods, vol. 601","author":"Eriksson","year":"1997"},{"key":"10.1016\/j.jaad.2013.09.010_bib130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00128071-200304070-00004","article-title":"Topical acne drugs: review of clinical properties, systemic exposure, and safety","volume":"4","author":"Akhavan","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2013.09.010_bib131","doi-asserted-by":"crossref","first-page":"F436","DOI":"10.1136\/fn.88.5.F436","article-title":"Congenital leukaemia after heavy abuse of permethrin during pregnancy","volume":"88","author":"Borkhardt","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jaad.2013.09.010_bib132","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-0528.2007.01290.x","article-title":"Safety of benzyl benzoate lotion and permethrin in pregnancy: a retrospective matched cohort study","volume":"114","author":"Mytton","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.jaad.2013.09.010_bib133","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00002018-200023030-00006","article-title":"Risk classification systems for drug use during pregnancy: are they a reliable source of information?","volume":"23","author":"Addis","year":"2000","journal-title":"Drug Safety"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213009614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:29:10Z","timestamp":1759271350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213009614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0190962213009614"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.010","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of dermatologic medications in pregnancy and lactation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}